Currently, in the treatment of bladder cancer the use of robotics has entered in clinical practice, therefor robotic radical cystectomy with or without reconstruction is offered to patients during counseling procedures, if deemed appropriate and possible. The aim of the study is therefore the long-term evaluation of the peri-post-operative, oncological and functional results of patients undergoing radical cystectomy, both with an open and robotic approach. This study will thus help to clarify the actual impact of robotic surgery
Study Type
OBSERVATIONAL
Enrollment
500
All the patients enrolled have undergone or will undergo radical cystectomy, with or without lymphadenectomy or urethrectomy All possibles urinary diversion are included, like ileal conduit, neobladder etc...
Careggi University Hospital
Florence, Tuscany, Italy
RECRUITINGNumber of participants who will die from bladder cancer
Bladder Cancer Specific Mortality after surgery
Time frame: From enrollment to late follow-up, up to 7 years
Number of participants who will experience bladder cancer recurrence
Bladder Cancer Recurrence
Time frame: From enrollment to late follow-up, up to 7 years
Number of participants who will die from all causes
All cause mortality after surgery
Time frame: From enrollment to late follow-up, up to 7 years
Number of participants who will die from bladder cancer after Robotic Surgery
Robotic surgery specific impact on survival
Time frame: From enrollment to late follow-up, up to 7 years
Number of participants who will experience bladder cancer recurrence after Robotic Surgery
Robotic surgery specific impact on recurrence
Time frame: From enrollment to late follow-up, up to 7 years
Number of participants who will experience surgical complications after Robotic Surgery
Robotic surgery specific impact on surgical complications
Time frame: From enrollment to late follow-up, up to 7 years
Variation in Quality of Life questionnaire after Robotic Surgery
Robotic surgery specific impact on quality of life according to European Organisation for Research and Treatment of Cancer (EORTC) core quality of life questionnaire (QLQ-C30)
Time frame: From enrollment to late follow-up, up to 7 years
Variation in Quality of Life questionnaire according to Urinary diversions
Urinary diversion specific impact on quality of life according to European Organisation for Research and Treatment of Cancer (EORTC) core quality of life questionnaire (QLQ-C30)
Time frame: From enrollment to late follow-up, up to 7 years
Number of participants who will experience surgical complications according to Urinary diversions
Urinary diversion specific impact on surgical complications
Time frame: From enrollment to late follow-up, up to 7 years
Number of participants who will experience bladder cancer recurrence according to Urinary diversions
Urinary diversion specific impact on bladder cancer recurrence
Time frame: From enrollment to late follow-up, up to 7 years
Number of participants who will die from bladder cancer according to Urinary diversions
Urinary diversion specific impact on bladder cancer rmortality
Time frame: From enrollment to late follow-up, up to 7 years
Number of participants who will die from all causes according to Urinary diversions
Urinary diversion specific impact on all cause mortality after surgery
Time frame: From enrollment to late follow-up, up to 7 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.